+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Hepatitis C Market Report 2025 - Product Thumbnail Image

Hepatitis C Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Fatty Liver Treatment Market Report 2025 - Product Thumbnail Image

Fatty Liver Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Scleroderma Market Report 2025 - Product Thumbnail Image

Scleroderma Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Cirrhosis- Pipeline Insight, 2025 - Product Thumbnail Image

Cirrhosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 200 Pages
  • Global
From
T-Cell Immunotherapy Market - Global Forecast 2025-2032 - Product Thumbnail Image

T-Cell Immunotherapy Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 188 Pages
  • Global
From
Allogeneic Cell Therapy - Global Strategic Business Report - Product Thumbnail Image

Allogeneic Cell Therapy - Global Strategic Business Report

  • Report
  • November 2025
  • 275 Pages
  • Global
From
Alcoholic Hepatitis Treatment Market Report 2025 - Product Thumbnail Image

Alcoholic Hepatitis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Myelodysplastic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Myelodysplastic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 504 Pages
  • Global
From
Dental Anesthesia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Dental Anesthesia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • August 2025
  • 180 Pages
  • Global
From
Pulmonary Arterial Hypertension Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Pulmonary Arterial Hypertension Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • August 2025
  • 188 Pages
  • Global
From
Novel T-Cell Immunotherapies Market: Focus on T-Cells, Tregs, Activated T-Cells, Virus-driven T-Cells & T-Cell Vaccines - Distribution by Type of T-Cell Therapy, Target Indications , Key Players and Key Geographies: Industry Trends and Global Forecasts, 2021-2030 - Product Thumbnail Image

Novel T-Cell Immunotherapies Market: Focus on T-Cells, Tregs, Activated T-Cells, Virus-driven T-Cells & T-Cell Vaccines - Distribution by Type of T-Cell Therapy, Target Indications , Key Players and Key Geographies: Industry Trends and Global Forecasts, 2021-2030

  • Report
  • June 2021
  • 193 Pages
  • Global
From
Ankylosing Spondylitis Market - Global Forecast 2025-2032 - Product Thumbnail Image

Ankylosing Spondylitis Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 182 Pages
  • Global
From
Pulmonary Arterial Hypertension Market Report 2025 - Product Thumbnail Image

Pulmonary Arterial Hypertension Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
US Healthcare Outlook Report, 2025 - Product Thumbnail Image

US Healthcare Outlook Report, 2025

  • Report
  • April 2025
  • 60 Pages
  • United States
From
COVID-19 (Coronavirus) Global Market Conditions and Competitors: Cell Therapies, Diagnostics, Treatments, Trials, & Vaccines - Product Thumbnail Image

COVID-19 (Coronavirus) Global Market Conditions and Competitors: Cell Therapies, Diagnostics, Treatments, Trials, & Vaccines

  • Report
  • July 2020
  • 269 Pages
  • Global
From
Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • December 2022
  • 566 Pages
  • Global
From
5-Alpha Reductase Deficiency Market Report 2025 - Product Thumbnail Image

5-Alpha Reductase Deficiency Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Gene Editing beyond CRISPR Market: Focus on Zinc Finger Nucleases, Transcription Activator-Like Effector Nucleases and Meganucleases Edited Therapies: Distribution by Type of Payment and Distribution by Geography: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Gene Editing beyond CRISPR Market: Focus on Zinc Finger Nucleases, Transcription Activator-Like Effector Nucleases and Meganucleases Edited Therapies: Distribution by Type of Payment and Distribution by Geography: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • January 2022
  • 151 Pages
  • Global
From
Primary Sclerosing Cholangitis (PSC) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Primary Sclerosing Cholangitis (PSC) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • September 2024
  • 193 Pages
  • Global
From
Myelodysplastic Syndrome (MDS) Drugs Market Report 2025 - Product Thumbnail Image

Myelodysplastic Syndrome (MDS) Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Loading Indicator